Vertaling van "prevent and control the emergence " (Nederlands → Frans) :

75. Goldmann DA et al: Strategies to prevent and control the emergence and spread of antibiotic-resistant microorganisms in hospitals.
75. Goldmann DA et al : Stratégies to prevent and control thé emergence and spread of antibiotic-résistant microorganisms in hospitals.

Workshop to prevent and control the emergence and spread of antibioticresistant microorganism in hospital.
Workshop to prevent and control thé émergence and spread of antibioticresistant microorganism in hospital.

CDAD: Clostridium difficile geassocieerde diarree (C. difficile - associated diarrhea) CDC: Centers for Disease Control and Prevention (U.S. Department of Health & Human Services) CCFA: Cycloserine Cefoxitine Fructose agar (selectieve cultuurmedia) CFU: Colony-forming units CIA: chromatographic immunoassay CPE: Cytopathogeen effect ECDC: European Centre for Disease Prevention and Control EIA: Enzyme Immunoassay ELISA: Enzyme-Linked Immunosorbent Assay GHD: Glutamate dehydrogenase HGR: Hoge Gezondheidsraad (CSS) HIV: Human immunodeficiency virus Ig: Immunoglobulin (antilichaam) MRSA: Methicillin Resistant Staphylococcus aureus NaDDC: Natriumdichloorisocyanuraat dihydraat (buffer) PCR: Polymerase Chain Reaction. ppm: Parts per million VRE: Vancomycin-Resistant Enterococci.
CDAD: Diarrhée associée à Clostridium difficile (C. difficile - associated diarrhoea) CDC: Centers for Disease Control and Prevention (U.S. Department of Health & Human Services) CCFA: Cyclosérine Céfoxitine Fructose agar (milieux de culture sélectifs) CFU: Colony-forming units CIA: chromatographic immunoassay CSS ou CSS-HGR: Conseil Supérieur de la Santé ECDC: European Centre for Disease Prevention and Control ECP: Effet cytopathogène EIA: Enzyme immunoassay ELISA: Enzyme-linked immunosorbent assay EPI: Equipement de protection individuel GDH: glutamate déshydrogénase Ig: Immunoglobuline ISP (WIV-IPH): Institut Scientifique de Santé Publique.

MeSH Keywords Sleutelwoorden Mots clés Stichworten terms* Hospital Construction Constructie Construction Konstruktion Design and Renovation Renovatie Rénovation Renovierung Construction Transformation Verbouwing Transformation Umbau Health Health care Zorginstellingen Institutions de Krankenpflegeeinrichtungen Facilities settings soins Infection Prevention Preventie Prévention Prävention Control Infection Infectie Infection Infektion Aspergillus Aspergillus Aspergillus Aspergillus Aspergillus Legionella Legionella Legionella Legionella Legionella
MeSH Keywords Mots clés Sleutelwoorden Stichworten terms* Hospital Construction Construction Constructie Konstruktion Design and Renovation Rénovation Renovatie Renovierung Construction Transformation Transformation Verbouwing Umbau Health Health care Institutions de Zorginstellingen Krankenpflegeeinrichtungen Facilities facilities soins Infection Control Prévention Preventie Prävention Control Infection Infection Infectie Infektion Aspergillus Aspergillus Aspergillus Aspergillus Aspergillus Legionella Legionella Legionella Legionella Legionella

Volgens “Prevention and control of nosocomial infections 4th edition by Wenzel Richard – 2003 Lippincott, Williams & Wilkins. Chapter Occupational exposure to bloodborne pathogens: epidemiology and prevention. Table 1”.
D’après “Prevention and control of nosocomial infections 4th edition by Wenzel Richard – 2003 Lippincott, Williams & Wilkins ” Chapter Occupational exposure to bloodborne pathogens: epidemiology and prevention” Table.

The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT).JAMA 2002; 288: 2981-2997 (5) PAHOR M, PSATY B, ALERMAN M et al. Health outcomes associated with antagonists compared with other firstline antihypertensive therapies : a meta-analysis of randomised controlled trials.
The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2002 ; 288 : 2981-2997 (5) PAHOR M, PSATY B, ALERMAN M et al. Health outcomes associated with antagonists compared with other firstlineantihypertensive therapies : a meta-analysis of randomised controlled trials.

Dat mag echter niemand meer het argument geven dat CVS een niet objectiveerbare aandoening is” (Center for Disease Control and Prevention, AACFS, Madison 10.10.2004).
Cela ne permet toutefois pas de dire que le SFC est une affection non objectivable» (Center for Disease Control and Prevention, AACFS, Madison, 10.10.2004).

Volgens professor Dr. William C. REEVES, Harvard University, die voor de Amerikaanse Centers for Disease Control and Prevention CVS opvolgt, “zijn we het er voor eens en altijd over eens dat CVS een biologische achtergrond heeft.
Selon le professeur William C. REEVES de l’Université de Harvard, chargé du suivi du SFC au nom des Centers for Disease Control and Prevention américains, « nous admettons une fois pour toutes que le SFC a une origine biologique.

26. Recommendations for preventing the spread of vancomycin resistance: recommandations of the Hospital Infection Control Practices Advisory Committee (HICPAC).
26. Recommendations for preventing the spread of vancomycin resistance : recommandations of the Hospital Infection Control Practices Advisory Committee (HICPAC).

16. Mc Gowan JE Jr: Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance?
16. Mc Gowan JE Jr : Do intensive hospital antibiotic control programs prevent thé spread of antibiotic resistance ?